These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3960166)

  • 1. [Diltiazem: a new calcium antagonist in the Netherlands].
    Robbens EJ; Hagemeijer F
    Ned Tijdschr Geneeskd; 1986 Mar; 130(12):535-7. PubMed ID: 3960166
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dilzem - a new calcium antagonist is introduced].
    Bohl E
    ZFA (Stuttgart); 1982 Feb; 58(5):292-6. PubMed ID: 7080650
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium antagonism--with special reference to diltiazem.
    Kendall MJ; Okopski JV
    J Clin Hosp Pharm; 1986 Jun; 11(3):159-74. PubMed ID: 3528227
    [No Abstract]   [Full Text] [Related]  

  • 6. Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart.
    Hamm CW; Opie LH
    Circ Res; 1983 Feb; 52(2 Pt 2):I129-38. PubMed ID: 6831647
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective improvement in subendocardial perfusion distal to a flow-limiting coronary artery stenosis: effects of the new calcium channel blocking agent, FR 34235, nifedipine and diltiazem.
    Gross GJ; Warltier DC
    J Pharmacol Exp Ther; 1984 Mar; 228(3):531-6. PubMed ID: 6707908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diastolic properties of the left ventricle in hypertensive cardiopathy. Acute effect of nifedipine, verapamil and diltiazem].
    Alonso Gómez AM; Monreal F; Villafranca JL; Cabello JB; de Diego JM
    Rev Esp Cardiol; 1984; 37(3):169-74. PubMed ID: 6505349
    [No Abstract]   [Full Text] [Related]  

  • 9. Calcium channel blockers: rationale for their clinical use.
    Conti CR
    J Fla Med Assoc; 1981 Nov; 68(11):883-6. PubMed ID: 6120992
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of diltiazem hydrochloride in cardiovascular disorders.
    McAuley BJ; Schroeder JS
    Pharmacotherapy; 1982; 2(3):121-33. PubMed ID: 6763199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparative effects of diltiazem and verapamil on atrioventricular conduction and atrioventricular reentry tachycardia.
    Rowland E; McKenna WJ; Gülker H; Krikler DM
    Circ Res; 1983 Feb; 52(2 Pt 2):I163-8. PubMed ID: 6831649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium channel blocking drugs.
    Johnston WE; Lowenstein E
    Contemp Anesth Pract; 1983; 7():163-91. PubMed ID: 6309475
    [No Abstract]   [Full Text] [Related]  

  • 13. The beneficial effect of a calcium channel blocker, Diltiazem, on the ischemic-reperfused heart.
    Weishaar RE; Bing RJ
    J Mol Cell Cardiol; 1980 Oct; 12(10):993-1009. PubMed ID: 6257916
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of diltiazem on calcium transport and development of tension in heart muscle.
    Morad M; Tung L; Greenspan AM
    Am J Cardiol; 1982 Feb; 49(3):595-601. PubMed ID: 6277180
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative evaluation of the vasodilator effect of verapamil, nifedipine and diltiazem on isolated perfused coronary arteries of rabbit.
    Kaur AH; Singh M; Singh J
    Indian J Physiol Pharmacol; 1984; 28(3):206-10. PubMed ID: 6519762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calcium antagonists: sites of action, pharmacological effect profile and clinical use. 1: Physiologic significance of calcium ions and mechanisms of action of calcium antagonists in the subcellular area].
    Bluth R; Langnickel R
    Z Arztl Fortbild (Jena); 1986; 80(5):191-7. PubMed ID: 2424181
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of diltiazem, a calcium antagonist: coronary vasodilating and antihypertensive actions.
    Nagao T; Narita H; Sato M; Nakajima H; Kiyomoto A
    Clin Exp Hypertens A; 1982; 4(1-2):285-96. PubMed ID: 7074990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular characterization of SD-3211, a novel benzothiazine calcium channel blocker, in isolated rabbit hearts.
    Miyawaki N; Furuta T; Shigei T; Yamauchi H; Iso T
    Life Sci; 1991; 48(20):1903-9. PubMed ID: 2023522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium channel blocking agents.
    Ewy GA
    Med Times; 1981 Aug; 109(8):36-8. PubMed ID: 6268924
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of diltiazem on conduction of premature impulses during acute myocardial ischemia and reperfusion.
    Fujimoto T; Peter T; Hamamoto H; Mandel WJ
    Am J Cardiol; 1981 Nov; 48(5):851-7. PubMed ID: 6272563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.